Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection.
Feline immunodeficiency virus (FIV)
Human immunodeficiency virus (HIV)
Nucleocapsid protein
Selenium
Zinc ejection
Journal
Bioorganic & medicinal chemistry letters
ISSN: 1464-3405
Titre abrégé: Bioorg Med Chem Lett
Pays: England
ID NLM: 9107377
Informations de publication
Date de publication:
15 07 2019
15 07 2019
Historique:
received:
05
04
2019
accepted:
08
05
2019
pubmed:
19
5
2019
medline:
10
9
2020
entrez:
19
5
2019
Statut:
ppublish
Résumé
We report the first biological evaluation the 1,2,3-thiaselenazole class of compound and utilising a concise synthetic approach of sulfur extrusion, selenium insertion of the 1,2,3-dithiazoles. We created a small diverse library of compounds to contrast the two ring systems. This approach has highlighted new structure activity relationship insights and lead to the development of sub-micro molar anti-viral compounds with reduced toxicity. The 1,2,3-thiaselenazole represents a new class of potential compounds for the treatment of FIV and HIV.
Identifiants
pubmed: 31101470
pii: S0960-894X(19)30302-6
doi: 10.1016/j.bmcl.2019.05.016
pii:
doi:
Substances chimiques
Antiviral Agents
0
Nucleocapsid Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1765-1768Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.